Skip to main content

Table 1 Patients characteristics – from chart review

From: Treatment patterns and real world clinical outcomes in ER+/HER2- post-menopausal metastatic breast cancer patients in the United States

Variable Level N Mean SD
Age at data extraction or death   178 65.83 9.35
Age at initial BC diagnosis   178 61.49 9.69
Age at progression to metastatic disease   178 62.85 9.39
    n %
Stage at diagnosis Early (Stage IA, IB, IIA, IIB)   40 22.5%
  Limited Regional (Stage IIIA)   8 4.5%
  Locally Advanced (Stage IIIB)   6 3.4%
  Locally Advanced (Stage IIIC)   5 2.8%
  Metastatic (Stage IV)   119 66.9%
ECOG performance status at the time of diagnosis of mBCa 0   63 35.4%
1   96 53.9%
2   18 10.1%
3   1 0.6%
Adjuvant treatment received (history) Yes   65 36.5%
No   111 62.4%
Don’t know   2 1.1%
  1. BC breast cancer; ECOG: Easter Cooperative Oncology Group; mBC: metastatic breast cancer
  2. aDefinition of ECOG performance statuses; 0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light house work, office work; 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3: Capable of only limited self-care, confined to bed or chair more than 50% of walking hours